이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Family Caregiving Role Adjustment and Dyadic Mutuality

2019년 12월 13일 업데이트: National Institutes of Health Clinical Center (CC)

Family Caregiving Role Adjustment and Dyadic Mutuality: A Mixed Methods Study

Background:

Cancer causes changes in the lives of patients and in the lives of their caregivers. Patients and caregivers feel stress and they affect each other as they deal with these changes. They each cope with cancer diagnosis and treatment on their own. They also cope together. Researchers want to explore this shared change of roles and responsibilities. They will do this by gaining insight into the social experience of cancer caregiving. They also want to better understand the ways caregiver/patient teams manage the cancer diagnosis and experience. This can help find new ways to support caregivers and their patients.

Objective:

To explore the shared change of roles and responsibilities of patients and caregivers by studying the social experience of cancer caregiving.

Eligibility:

English speakers ages 18 and older who are one of the following:

A cancer patients at the NIH Clinical Center (CC)

A caregiver of a CC cancer patient

Design:

Participants will have been screened by the CC.

Patients and caregivers will be interviewed separately. This will last up to an hour and a half.

Participants will complete online surveys.

Participants may have a follow-up phone interview. This will last up to 15 minutes.

연구 개요

상세 설명

Family caregiving is recognized as a significant public health problem, with approximately 66 million adult family caregivers in the United States providing services valued at an estimated $450 billion per year. These individuals are considered informal caregivers, in contrast to formal, paid caregivers such as nurses. Family caregivers suffer role strain and burden of caring that increases their risk for morbidity and mortality, which is the reason why they have been the focus of much caregiver research in recent decades. Improving health outcomes for family caregivers of cancer patients has involved developing approaches to reduce stress by boosting caregiver preparedness, mastery, and self-efficacy; however, in recent years there has been a progressive shift in the way the cancer caregiving experience has been characterized. This characterization has moved away from a focus on the individual to a focus on the caregiver-patient dyad. This shift has occurred, in part, because research has shown that each person in the dyad impacts the way in which the other person adjusts to his/her new role and responsibilities. Thus, the way this occurs is important since these adjustments not only influence the health of the dyadic relationship but also impact the couple s overall well-being.

Current focus on mutual or dyadic coping with cancer diagnosis and treatment stems from the understanding that caregivers and patients work individually, but also together to manage their shared stress and to make meaning out of their mutual experience. Because of this, mutuality and interdependence in dyadic coping extend beyond social support. Dyads collaborate, negotiate, and problem-solve to jointly manage stress and make decisions related to a diagnosis such as cancer. However, there has been little systematic inquiry into the dynamics of shared role adjustment in the cancer family caregiving dyad even though the stress of chronic illness appears to affect both the patient and the caregiver s well-being. The social experience of managing an illness such as cancer and the adjustments made to accommodate the new life situation are the first steps in what is often a prolonged disease trajectory that will require many other changes and transitions along the way.

Therefore, the primary objective for this study conducted in phase one is to explore family caregiver and care recipient mutual negotiation of roles and responsibilities by gaining insight into the social experience of cancer family caregiving that will have application to practice and guide further study. Phase two is contingent upon sample size, with the goal to further explore quantitative measures of individual caregiver and patient as well as dyadic well-being with regard to role adjustment and mutuality. A particular focus will be on dyads who are flourishing and those who are collaborating, to determine what they are doing differently.

A convergent parallel mixed methods study will be conducted using a grounded theory approach to data collection and analysis. A purposive sample of cancer patient participants and their designated family caregiver will be recruited from the National Institutes of Health Clinical Center. Final sample size will depend on conceptual and theoretical saturation, with an anticipated sample to include approximately 20 caregiver-patient dyads. A focused interview guide with open ended questions and probes will be used. During data collection and analysis, data will be compared to previous interviews and to the literature so that gaps in the developing framework can be identified and questions for subsequent interviews adjusted. To capture the experiences and perceptions of the interviewee, interviews with caregivers and care recipient participants will be conducted separately and by the same researcher. During analysis, both interviews will be analyzed on the level of the patient, of the family caregiver, and of the dyadic interaction (e.g. of categories and themes) between the two. Participants will also complete a socio-demographic questionnaire, Neuro QoL Ability to Participate in Social Roles and Activities, and Satisfaction with Social Roles and Activities-Short Forms, the Family Caregiving Inventory for Mutuality Scale, and the Mental Health Continuum-Short Form. This quantitative data will be triangulated and merged with conceptual categories from the caregiver and the care recipient interviews and will be used to compare subgroups to further illuminate qualitative findings.

Sacrifices caregivers make can lead to burden and stress, or to positive adjustment and growth. Through a better understanding of role adjustment and dyadic mutuality, we believe it will be possible to identify novel ways to support caregivers and their patients as they cope day to day and look toward the future.

연구 유형

관찰

등록 (실제)

24

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Maryland
      • Bethesda, Maryland, 미국, 20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

  • INCLUSION CRITERIA:

Patient participants will be recruited if they are at least 18 years of age, have a cancer diagnosis and are a patient at the NIH Clinical Center. They must be at least 6 weeks from the end of active treatment, be in a cancer caregiving situation with a spouse, partner (including non-traditional partner), significant other, family member or friend, be able to read and write English, and participate in a verbal interview (either face to face or by phone).

Caregiver Participants will be identified by the patient as the most involved in caregiving and therefore most likely the designated caregiver. The dyadic relationship will be co-defined and co-confirmed by both parties based on the researcher s understanding of dyadic dynamics. Caregiver participants will also be at least 18 years of age, be a spouse or partner (including non-traditional partner), significant other, family member or friend, be involved in the cancer caregiving situation with the care recipient for at least 6 months, be able to read and write English, and be able to participate in a verbal interview (either face to face or by phone).

EXCLUSION CRITERIA:

Patient participants will be excluded if under age 18, are not fully aware of diagnosis and treatment, if they are not a spouse or partner , (including non-traditional partner), significant other, family member or friend, if they are unable to participate in a verbal interview (either face to face or by phone) or are unable to read

or write English. A patient who has enrolled with one caregiver cannot enroll with another caregiver. A single caregiver must be identified for the duration of the protocol.

Caregiver Participants will be excluded if they are under age 18, are not the designated person identified by the care recipient as being most involved in their care, and if they are not a spouse or partner , (including non-traditional partner), significant other, family member or friend, if they are unable to participate in a verbal interview (either by face to face or by phone), or are unable to read or write English.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Role Adjustment
기간: on-going for Phase I
by gaining insights into the social experience of cancer family caregiving that will have application to practice and guide further study
on-going for Phase I
Mutuality
기간: on-going for Phase I
by gaining insights into the social experience of cancer family caregiving that will have application to practice and guide further study
on-going for Phase I

2차 결과 측정

결과 측정
기간
Patient and caregiver mutuality effect on patient well-being
기간: 9/1/2017
9/1/2017
Patient and caregiver mutuality effect on caregiver well-being
기간: 9/1/2017
9/1/2017

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Margaret F Bevans, R.N., National Institutes of Health Clinical Center (CC)

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2015년 10월 1일

기본 완료 (실제)

2017년 8월 24일

연구 완료 (실제)

2019년 9월 18일

연구 등록 날짜

최초 제출

2015년 10월 1일

QC 기준을 충족하는 최초 제출

2015년 10월 1일

처음 게시됨 (추정)

2015년 10월 2일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2019년 12월 16일

QC 기준을 충족하는 마지막 업데이트 제출

2019년 12월 13일

마지막으로 확인됨

2019년 9월 18일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 999915206
  • 15-CC-N206

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다